View More View Less
  • 1 Pécsi Tudományegyetem, Klinikai Központ, Pécs, Dischka Győző u. 5., 7621
  • 2 Pécsi Tudományegyetem, Klinikai Központ, Pécs
  • 3 Pécsi Tudományegyetem, Klinikai Központ, Pécs
Open access

Absztrakt:

A Gorlin–Goltz-szindróma autoszomális dominánsan öröklődő kórkép. Vezető tünetei az állcsontok keratocystái, a multiplex basaliomák, csontvázfejlődési rendellenességek, intracranialis calcificatio és tenyéri, talpi dyskeratosis. A szindróma egyik leggyakoribb és sokszor először észrevehető tünete az állcsonti keratocysta. A szerzők munkájukban egy fogszabályozó osztályon diagnosztizált és kezelt gyermek esetét mutatják be. A betegség ritka előfordulása ellenére fontos a korai, fiatalkorban történő felismerés. A betegek rendszeres gondozásával megelőzhetők az akár életet veszélyeztető elváltozások és a radikális műtéttel járó kezelések. Orv Hetil. 2020; 161(2): 67–74.

If the inline PDF is not rendering correctly, you can download the PDF file here.

  • 1

    Gorlin RJ, Goltz RW. Multiple naevoid basal-cell epithelioma, jaw cysts and bifid rib. A syndrome. N Engl J Med. 1960; 262: 908–912.

  • 2

    Levanant S, Gorlin R, Fallet S, et al. A two-hit model for developmental defects in Gorlin syndrome. Nature Genet. 1996; 12: 85–87.

  • 3

    Gailani MR. The role of the human homologue of Drosophila patched in sporadic basal cell carcinomas. Nature Genet. 1996; 14: 78–81.

  • 4

    Gyenes V, Pataky L, Csiba A. Gorlin–Goltz syndrome. [Gorlin–Goltz szindróma.] Orv Hetil. 1981; 122: 1967–1969. [Hungarian]

  • 5

    Újpál M, Szabó Gy. Gorlin–Goltz syndrome. [Gorlin–Goltz szindróma.] Fogorv Szle. 1992; 85: 209–212. [Hungarian]

  • 6

    Gorlin RJ, Cohen MM, Levin LS. Syndromes of the head and neck. Third edition. Oxford University Press, New York, NY, 1992; pp. 365–380.

  • 7

    Kiss T, Liszkay G, Oberna F. Gorlin–Goltz syndrome. [Gorlin–Goltz-szindróma.] Bőrgyógy Venerol Szle. 2008; 84: 55–59. [Hungarian]

  • 8

    Anehosur V. Gorlin’s syndrome – report of a case and management of cystic lesions. J Maxillofac Oral Surg. 2009; 8: 184–187.

  • 9

    Barnes L, Eveson JW, Reichart P, et al. Pathology and genetics of head and neck tumours, WHO classification of tumours. 3rd edition, volume 9. IARC (International Agency for Research on Cancer), Lyon, 2005.

  • 10

    El-Naggar AK, Chan JKC, Grandis JR, et al. WHO classification of head and neck tumours. 4th edition, volume 9. IARC (International Agency for Research on Cancer), Lyon, 2017.

  • 11

    Speight PM, Takata T. New tumour entities in the 4th edition of the World Health Organization classification of head and neck tumours: odontogenic and maxillofacial bone tumours. Virchows Arch. 2017; 472: 331–339.

  • 12

    Stoelinga PJ. Long-term follow-up on keratocysts treated according to a defined protocol. Int J Oral Maxillofac Surg. 2001; 30: 14–25.

  • 13

    Regezi JA. Odontogenic cysts, odontogenic tumors, fibroosseous, and giant cell lesions of the jaws. Mod Pathol. 2002; 15: 331–341.

  • 14

    Khaliq MIU, Shah AA, Ahmad I, et al. Keratocystic odontogenic tumors related to Gorlin–Goltz syndrome: a clinicopathological study. J Oral Biol Craniofac Res. 2016; 6: 93–100.

  • 15

    Brøndum N, Jensen VJ. Recurrence of keratocysts and decompression treatment. A long-term follow-up of forty-four cases. Oral Surg Oral Med Oral Pathol. 1991; 72: 265–269.

  • 16

    Chirapathomsakul D, Sastravaha P. A review of odontogenic keratocysts and the behavior of recurrences. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2006; 101: 5–9.

  • 17

    Giuliani M, Grossi GB, Lajolo C, et al. Conservative management of a large odontogenic keratocyst: report of a case and review of the literature. J Oral Maxillofac Surg. 2006; 64: 308–316.

  • 18

    Morgan TA, Burton CC, Qian F. A retrospective review of treatment of the odontogenic keratocyst. J Oral Maxillofac Surg. 2005; 63: 635–639.

  • 19

    Voorsmit RA, Stoelinga PJ, van Haelst UJ. The management of keratocysts. J Maxillofac Surg. 1981; 9: 228–236.

  • 20

    Stoelinga PW. The treatment of odontogenic keratocysts by excision of the overlying, attached mucosa, enucleation, and treatment of the bony defect with Carnoy solution. J Oral Maxillofac Surg. 2005; 63: 1662–1666.

  • 21

    Pogrel MA. The use of liquid nitrogen cryotherapy in the management of locally aggressive bone lesions. J Oral Maxillofac Surg. 1993; 51: 269–273.

  • 22

    Schmidt BL. Neurosensory changes following cryotherapy. J Oral Maxillofac Surg. 1999; 57: 46.

  • 23

    Blanas N, Freund B, Schwartz M, et al. Systematic review of the treatment and prognosis of the odontogenic keratocyst. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2000; 90: 553–558.

  • 24

    Basset-Seguin N, Bissonnette R, Girard C, et al. Consensus recommendations for the treatment of basal cell carcinomas in Gorlin syndrome with topical methylaminolaevulinate-photodynamic therapy. J Eur Acad Dermatol Venereol. 2014; 28: 626–632.

  • 25

    García de Marcos JA, Dean-Ferrer A, Arroyo Rodríguez S, et al. Basal cell nevus syndrome: clinical and genetic diagnosis. Oral Maxillofac Surg. 2009; 13: 225–230.

  • 26

    Yoon J, Apicelli AJ, Pavlopoulos TV, et al. Intracranial regression of an advanced basal cell carcinoma using sonidegib and itraconazole after failure with vismodegib. J Am Acad Dermatol Case Reports 2018; 4: 10–12.

  • 27

    Xie P, Lefrancois P. Efficacy, safety, and comparison of sonic hedgehog inhibitors in basal cell carcinomas: A systematic review and meta-analysis. J Am Acad Dermatol. 2018; 79: 1089–1100.

  • 28

    Szüts J, Németh Zs. Diagnostic and therapeutic aspects of odontoms in maxillofacial surgery. [Odontomák diagnosztikus és terápiás aspektusai a maxillofaciális sebészetben.] Fogorv Szle. 2018; 111: 85–90. [Hungarian]

  • 29

    Manfredi M, Vescovi P, Bonanini M, et al. Naevoid basal cell carcinoma syndrome: a review of the literature. Int J Oral Maxillofac Surg. 2004; 33: 117–124.

  • 30

    Kimonis VE, Goldstein AM, Pastakia B, et al. Clinical manifestations in 105 persons with naevoid basal cell carcinoma syndrome. Am J Med Gen. 1997; 69: 299–308.

  • 31

    Evans DG, Ladusans EJ, Rimmer S, et al. Complications of the naevoid basal cell carcinoma syndrome: results of a population based study. J Med Genet. 1993; 30: 460–464.

  • 32

    Ahn SG, Lim YS, Kim DK, et al. Naevoid basal cell carcinoma syndrome: a retrospective analysis of 33 affected Korean individuals. Int J Oral Maxillofac Surg. 2004; 33: 458–462.

  • 33

    Dahl E, Kreiborg S, Jensen BL. Craniofacial morphology in basal cell carcinoma syndrome. Int J Oral Surg. 1976; 5: 300–310.

  • 34

    Van Dijk E, Neering H. The association of cleft lip and palate with basal cell naevus syndrome. Oral Surg. 1980; 50: 214–216.

  • 35

    Seracchioli R, Bagnoli A, Colombo FM, et al. Conservative treatment of recurrent ovarian fibromas in a young patient affected by Gorlin syndrome. Hum Reprod. 2001; 16: 1261–1263.

  • 36

    Ponti G, Pastorino L, Pollio A. Ameloblastoma: a neglected criterion for nevoid basal cell carcinoma (Gorlin) syndrome. Fam Cancer 2012; 11: 411–418.

  • 37

    Kiss P. (ed.) Atlas of syndromes. [Szindrómaatlasz.] Golden Book Kiadó, Budapest, 2000; pp. 62–63. [Hungarian]

  • 38

    Shahmoradi Z, Andalib F, Siadat AH. Naevoid basal cell carcinoma syndrome. Indian J Dermatol Venereol Leprol. 2010; 76: 71–73.

  • 39

    Shivaswamy KN, Sumathy TK, Shyamprasad AL, et al. Gorlin syndrome or basal cell nevus syndrome (BCNS): a case report. Dermatol Online J. 2010; 16: 6.

  • 40

    Pogrel MA. Treatment of keratocysts: the case for decompression and marsupialization. J Oral Maxillofac Surg. 2005; 63: 1667–1673.

  • 41

    Partsch C. Treatment of jaw cysts. [Zur Behandlung der Kieferzysten.] Dtsch Monatsschr Zahnheilk. 1910; 252: 28. [German]

  • 42

    Maurette PE, Jorge J, de Moraes M. Conservative treatment protocol of odontogenic keratocyst: a preliminary study. J Oral Maxillofac Surg. 2006; 64: 379–383.

  • 43

    Bataineh AB, Al Qudah M. Treatment of mandibular odontogenic keratocysts. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 1998; 86: 42–47.

  • 44

    Peraza A, González L, González N. Outcome after 8 years of a modified conservative treatment experience in keratocystic odontogenic tumor in 5 patients. Oral Maxillofac Surg Cases 2017; 3: 42–47.

  • 45

    Schmidt BL, Pogrel MA. The use of enucleation and liquid nitrogen cryotherapy in the management of odontogenic keratocysts. J Oral Maxillofac Surg. 2001; 59: 720–725. Discussion: 726–727.

  • 46

    Szabó Gy, Suba Zs, Barabás J, et al. Filling a triple mandibular cyst with different bone substitutes. [Hármas mandibula cysta feltöltése különböző csontpótló anyagokkal.] Quintessenz 2003; 2: 123–125. [Hungarian]